权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

EPISTEMOLOGY AND ETHICS OF QUALITY IMPROVEMENT

质量改进的认识论和伦理学

基本信息

批准号：
6460206
负责人：
DORCAS JOANNE LYNN
金额：
$ 5万
依托单位：
RAND CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-07-01 至 2002-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6460206
关键词：
clinical research ethics meeting /conference /symposium

项目摘要

This research conference, to be held December 8-9, 2001, will examine and develop a framework for articulating the epistemology of and ethical dilemmas produced by quality improvement (QI) efforts so as to suggest if current processes and procedures for protecting human research subjects are appropriately applied to QI work. The specific aims are to: 1. Articulate the major arguments about the nature of the knowledge that can be gained from quality improvement efforts and standards for assessing its validity. 2. Examine the potential risks, benefits and harms of QI and determine what levels of benefit are necessary, as well as what levels of risk are acceptable, for the performance of QI work. 3. Identify privacy concerns and informed consent considerations that arise from QI work. 4. Identify priority areas for research on the conceptual, ethical and empirical dimensions of quality improvement especially in areas that have specific importance in the regulation of QI with respect to protection of human subjects. The approximately 30 participants at the invitational conference will include: clinical researchers; health services researchers; researchers in anthropology, qualitative sociology and educational innovation; medical, nursing and allied health professionals engaged in QI; medical administrators with oversight roles in QI projects; risk managers; IRB members; ethicists; patient advocates; and government representatives (e.g. AHRQ). To develop the conference agenda, finalize the list of speakers and outline the conceptual issues to be discussed in the invited papers, a meeting of the planning committee will be held on July 15, 2000 at RAND offices in Arlington, VA. Four papers and a review of the literature will be commissioned for discussion as part of the conference agenda. After the conference, a manuscript synthesizing the conference insights on specific questions and methodological approaches will be prepared by Joanne Lynn, MD, Bruce Jennings, MA, Melissa M. Bottrell, MPH, PhDc, and other members of the planning committee. The manuscript will be submitted to professional journal and be made available on the World Wide Web. At least one presentation will be made at a professional meeting concerned with bioethics and research regulation.

这个研究会议，将于2001年12月8日至9日举行，将审查和制定一个框架，阐明质量改进（QI）的努力所产生的认识论和道德困境，以建议如果目前的过程和程序，保护人类研究对象适当地适用于QI工作。具体目标是： 1.阐述关于从质量改进工作中获得的知识的性质的主要论点，以及评估其有效性的标准。 2.检查QI的潜在风险、利益和危害，并确定对于QI工作的绩效，什么样的利益水平是必要的，以及什么样的风险水平是可以接受的。 3.识别QI工作中出现的隐私问题和知情同意考虑。 4.确定研究质量改进的概念，伦理和经验层面的优先领域，特别是在对QI保护人类受试者的监管具有特殊重要性的领域。邀请会议的约30名与会者将包括：临床研究人员;卫生服务研究人员;人类学，定性社会学和教育创新研究人员;从事QI的医疗，护理和专职医疗人员;在QI项目中发挥监督作用的医疗管理人员;风险管理人员; IRB成员;伦理学家;患者倡导者;和政府代表（例如AHRQ）。为了制定会议议程、确定发言者名单和概述邀请文件中将讨论的概念问题，计划委员会将于2000年7月15日在弗吉尼亚州阿灵顿的兰德公司办公室举行会议。作为会议议程的一部分，将委托讨论四篇论文和一篇文献评论。会议结束后，将由医学博士乔安妮林恩、硕士布鲁斯詹宁斯、硕士梅丽莎M. Bottrell，MPH，PhDc和规划委员会的其他成员。手稿将提交给专业期刊，并在万维网上提供。在有关生物伦理学和研究条例的专业会议上至少要作一次专题介绍。